Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,042 | -30,018 | -68,369 | -72,974 | -53,247 |
| Depreciation Amortization | 2,988 | 2,720 | 2,656 | 2,755 | 2,690 |
| Other Working Capital | -14,353 | 52,985 | -5,725 | 29,572 | -5,865 |
| Other Operating Activity | 2,027 | -2,366 | -742 | 9,872 | 2,665 |
| Operating Cash Flow | $-39,381 | $23,321 | $-72,180 | $-30,775 | $-53,757 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,534 | -1,419 | -740 | -503 | -1,056 |
| Purchase Sale Intangibles | N/A | 8,594 | N/A | N/A | N/A |
| Other Investing Activity | -2,873 | 6,049 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,407 | $4,630 | $-740 | $-503 | $-1,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -1,091 | -45,697 | 32,721 | 16,415 |
| Common Stock Issued | 77,758 | 383 | 14,915 | 130,135 | 840 |
| Other Financing Activity | -1,712 | -1,754 | -1,764 | -970 | -691 |
| Financing Cash Flow | $76,046 | $-2,462 | $-32,546 | $161,886 | $16,563 |
| Exchange Rate Effect | 728 | 648 | 7,745 | 1,527 | -3,002 |
| Beginning Cash Position | 128,689 | 102,575 | 197,575 | 89,724 | 127,881 |
| End Cash Position | 161,674 | 128,713 | 99,855 | 221,860 | 86,630 |
| Net Cash Flow | $32,986 | $26,138 | $-97,720 | $132,136 | $-41,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,381 | 23,321 | -72,180 | -30,775 | -53,757 |
| Capital Expenditure | -1,534 | -1,484 | -746 | -573 | -1,056 |
| Free Cash Flow | -40,915 | 21,838 | -72,926 | -31,347 | -54,812 |